These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2828894)

  • 1. Human monoclonal antibodies to Pseudomonas aeruginosa produced by EBV-transformed cells.
    Suzuki H; Okubo Y; Moriyama M; Sasaki M; Matsumoto Y; Hozumi T
    Microbiol Immunol; 1987; 31(10):959-66. PubMed ID: 2828894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human monoclonal antibodies that protect mice against challenge with Pseudomonas aeruginosa.
    Zweerink HJ; Gammon MC; Hutchison CF; Jackson JJ; Lombardo D; Miner KM; Puckett JM; Sewell TJ; Sigal NH
    Infect Immun; 1988 Aug; 56(8):1873-9. PubMed ID: 3135264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of stable cell lines producing anti-Pseudomonas aeruginosa monoclonal antibodies and their protective effects for the infection in mice.
    O'Oka H; Chonan E; Mizutani K; Fukuda T; Kuroiwa Y; Ono Y; Shigeta S
    Microbiol Immunol; 1992; 36(12):1305-16. PubMed ID: 1287405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic generation of antigen specific human monoclonal antibodies with therapeutical activities using active immunization.
    Lang AB; Fürer E; Senyk G; Larrick JW; Cryz SJ
    Hum Antibodies Hybridomas; 1990; 1(2):96-103. PubMed ID: 2129420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production and some properties of monoclonal antibodies against serotype strains of Pseudomonas aeruginosa.
    Yoshida K; Kimura F; Uchida K; Kawaharajo K; Koizumi N; Nakajima S; Nagaoka K
    J Pharmacobiodyn; 1989 Jul; 12(7):398-404. PubMed ID: 2512385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosa.
    Collins MS; Roby RE
    Am J Med; 1984 Mar; 76(3A):168-74. PubMed ID: 6424446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human monoclonal antibodies to Pseudomonas aeruginosa type-specific lipopolysaccharides, toxin A and Klebsiella capsular polysaccharides.
    Lang AB; Fürer E; Schürch U; Cross AS; Larrick JW; Cryz SJ
    Dev Biol Stand; 1990; 71():121-6. PubMed ID: 1698165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo activity of polyclonal and monoclonal human immunoglobulins G, M, and A against Pseudomonas aeruginosa lipopolysaccharide.
    Pier GB; Thomas D; Small G; Siadak A; Zweerink H
    Infect Immun; 1989 Jan; 57(1):174-9. PubMed ID: 2491835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A human-human hybridoma secreting anti-Pseudomonas aeruginosa exotoxin-A monoclonal antibody with highly potent neutralizing activity.
    Kuriyama M; Ichimori Y; Iwasa S; Tsukamoto K
    Cytotechnology; 1990 Jan; 3(1):31-7. PubMed ID: 1369271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human monoclonal antibodies to Pseudomonas aeruginosa alginate that protect against infection by both mucoid and nonmucoid strains.
    Pier GB; Boyer D; Preston M; Coleman FT; Llosa N; Mueschenborn-Koglin S; Theilacker C; Goldenberg H; Uchin J; Priebe GP; Grout M; Posner M; Cavacini L
    J Immunol; 2004 Nov; 173(9):5671-8. PubMed ID: 15494518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of a human monoclonal antibody that recognizes epitopes shared by Pseudomonas aeruginosa immunotype 1, 3, 4, and 6 lipopolysaccharides.
    Lang AB; Fürer E; Larrick JW; Cryz SJ
    Infect Immun; 1989 Dec; 57(12):3851-5. PubMed ID: 2509371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterohybridomas that secrete high levels of pseudomonas-specific therapeutic human monoclonal antibodies: their generation and large scale growth in an automated hollow fiber cell culture system.
    Gammon MC; Banas MH; Boccumini LE; Sigal NH; Zweerink HJ
    Cytotechnology; 1990 Jan; 3(1):51-60. PubMed ID: 1367460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The production of human monoclonal antibodies against Pseudomonas aeruginosa by human-mouse hybridoma technique].
    Ye D; Yan R; Li S; Peng H; Xu X
    Hua Xi Yi Ke Da Xue Xue Bao; 1991 Mar; 22(1):24-6. PubMed ID: 1774030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common protective antigen (OEP) of Pseudomonas aeruginosa.
    Abe C; Shionoya H; Hirao Y; Okada K; Homma JY
    Jpn J Exp Med; 1975 Oct; 45(5):355-9. PubMed ID: 817054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human anti-Pseudomonas aeruginosa outer membrane proteins IgG cross-protective against infection with heterologous immunotype strains of P. aeruginosa.
    Lee NG; Ahn BY; Jung SB; Kim YG; Lee Y; Kim HS; Park WJ
    FEMS Immunol Med Microbiol; 1999 Sep; 25(4):339-47. PubMed ID: 10497864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsis.
    Hemachandra S; Kamboj K; Copfer J; Pier G; Green LL; Schreiber JR
    Infect Immun; 2001 Apr; 69(4):2223-9. PubMed ID: 11254577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine against heterologous immunotype strains in a burned mouse model.
    Matthews-Greer JM; Gilleland HE
    J Infect Dis; 1987 Jun; 155(6):1282-91. PubMed ID: 3033095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic and protective properties of a murine lipopolysaccharide-specific monoclonal antibody in experimental Pseudomonas aeruginosa pneumonia in mice.
    Oishi K; Sonoda F; Miwa H; Tanaka H; Watanabe K; Matsumoto K; Pollack M
    Microbiol Immunol; 1991; 35(12):1131-41. PubMed ID: 1808464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of human monoclonal antibodies by the epstein-barr virus method.
    Steinitz M
    Methods Mol Biol; 2014; 1060():111-22. PubMed ID: 24037838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.